MENRAD, ANDREAS,MENSSEN, HANS DIETRICH,WAGNER, KAROLA
申请号：
CA2648109
公开号：
CA2648109C
申请日:
2007.04.05
申请国别(地区):
CA
年份:
2012
代理人:
摘要：
The invention refers to the use of a fusion protein comprising an interleukin-2 part and an antibody part, specifically recognising the extra domain B of fibronectin, for treatment of a special form of cancer. Further, the invention refers to a combination of (i) said fusion protein and (ii) a small molecule, namely gemcitabine. The fusion protein or the combination ca be used for the treatment of cancer, especially pancreatic cancer.
